Commercialized a highly effective skin cancer scanning device

Used for over 12 years and supported by more than 15 published clinical studies

Sponsored
Message: Q4

Hi Mike, 

On some of the other discussion forums, quite a few investors (including myself) are understandably frustrated about the lack of follow-up after Q3. What are your expectations for Q4 and beyond? Is there anything significant coming to assuage current shareholders and attract new ones? 

Thanks. 

Share
New Message
Please login to post a reply